-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the past decade, the therapeutic targets of inflammatory bowel disease have undergone profound changes
In the past decade, the therapeutic targets of inflammatory bowel disease have undergone profound changes
The researchers retrospectively analyzed data on patients with mild to moderate UC who received mesalazine treatment
The results of the study showed that patients who achieved clinical remission, endoscopic healing, deep remission, or histological remission had a lower median FC concentration
This study confirmed that even in patients with complete endoscopic healing of UC, FC concentration can be used to distinguish between patients with persistent microscopic inflammation and patients with histological remission
This study confirmed that even in patients with complete endoscopic healing of UC, FC concentration can be used to distinguish between patients with persistent microscopic inflammation and patients with histological remission
Toer W.
Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis.
Leave a message here